Single Cell Analysis Market | 10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co. are among key contributors
Competitive Benchmarking and Vendor Forecasts for 2022-2026
The single cell analysis market and it is expected to grow by $ 3165.98 million, accelerating at a CAGR of almost 15.11% during the forecast period. The market is fragmented. The research report provides insights into the top market players and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. Market players must distinguish their product and service offerings through a clear and unique value proposition in order to secure a substantial share of the market. This report will provide a detailed study of the key players with insights into their product portfolio and future pipeline.
10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, and Sartorius AG are some of the major participants in the market.
For vendor analysis and product pipeline:
Single Cell Analysis Market: Market Highlights
- The Single cell analysis market is segmented by Product (Consumables and Instrument) and Geographic (North America, Europe, Asia, and Rest of World (ROW)).
- North America led the market with 45% of the market growth set to originate from this region during the forecast period.
- Increasing prevalence of cancer is one of the primary factors driving the growth of the single cell analysis market.
- The report provides a detailed study of this and all the other drivers that will boost market growth. An understanding of the key drivers will enable clients to leverage growth opportunities to their advantage with a view to short-term and long-term business goals. For more insights on this market: Download a Free Sample Report
Browse through some of our other related market research reports for more insights:
- Cell Sorting Market: Accelerating at a CAGR of 7%, the cell sorting market is expected to post an incremental growth of $ 83.63 million till 2023.
- Sickle Cell Disease Treatment Market: Global sickle cell disease treatment market is likely to post an incremental growth of $ 2.33 billion, accelerating at a CAGR of 11.36% during the forecast period.
- Stem Cell Banking Market: The stem cell banking market is expected to grow by $ 4.61 billion, accelerating at a CAGR of almost 8.08% during the forecast period.
- Hematopoietic Stem Cells Transplantation (HSCT) Market: Global hematopoietic stem cells transplantation (HSCT) market is likely to post an incremental growth of $ 1.99 billion, accelerating at a CAGR of over 6% during the forecast period.
Key Focus Areas in Our Reports:
- Market segments
- Comparison by Product
- Filleting and skinning equipment - Market size and forecast 2020-2025
- De-heading and gutting equipment - Market size and forecast 2020-2025
- Grading equipment - Market size and forecast 2020-2025
- Scaling equipment - Market size and forecast 2020-2025
- Others - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC - Market size and forecast 2020-2025
- MEA - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- North America - Market size and forecast 2020-2025
- South America - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- 10X Genomics Inc.
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- CellChorus Inc.
- DiaSorin SpA
- Fluidigm Corp.
- Illumina Inc.
- NanoString Technologies Inc.
- QIAGEN NV
- RareCyte Inc
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Yokogawa Electric Corp.
- Danaher Corp.
- Merck KGaA
- Sartorius AG
he report provides insights into the following FAQs:
- What is the market CAGR?
The market will accelerate at a CAGR of 15.11%.
- What is the incremental growth of the market?
The market is expected to grow by $ 3165.98 million through 2022-2026.
- What is a key factor driving this market?
Increasing prevalence of cancer will drive market growth over the forecast period.
- What are the key regions covered in this market research report?
North America, Europe, Asia, and Rest of World (ROW) are the key regions featured in this research report.
- Which is the leading geographic region for this market:
45% growth will originate from North America
- Who are the leading market vendors?
The leading vendors in this market are 10X Genomics Inc., Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., CellChorus Inc., DiaSorin SpA, Fluidigm Corp., Illumina Inc., NanoString Technologies Inc., QIAGEN NV, RareCyte Inc, Takara Bio Inc., Thermo Fisher Scientific Inc., Yokogawa Electric Corp., Danaher Corp., Merck KGaA, and Sartorius AG
- What are the market segments covered in this report?
The market is segmented by Product (Consumables and Instrument) and Geographic (North America, Europe, Asia, and Rest of World (ROW))
